Health Condition 1: K053- Chronic periodontitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: participants will be chosen on the basis of systemically healthy individual diagnosed with periodontitis stage II grade B with probing depth of more than 5 mm in at least two sites
Exclusion criteria
Exclusion criteria: Patients with hemogolobin level less than 11 mg/dL and having habit of smoking and pregnant women or patients under any antibiotic or anti inflammatory therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| : Injectable platelet rich fibrin (iPRF) as a vehicle for delivery of chlorhexidine will cause effective release of drug in periodontal pocket with improvement in clinical and microbial parameters at follow up.Timepoint: 15 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Injectable platelet rich fibrin (iPRF) based local chlorhexidine delivery will have better or comparable effectiveness when compared to commercially available chlorhexidine gel for delivery in periodontal pocket.Timepoint: 15 months | — |
Countries
India
Contacts
Government Dental College Raipur Chhattisgarh